The tweet was deleted by the author.
But we saved everything 🙂.
Twist Bioscience stock jumps 5.2% after research supports chemotherapy-induced metastasis findings
Twist Bioscience was selected by the @airdlab and its team to provide DNA for research examining how the chemotherapy-induced senescence-associated secretome influences cell detachment and metastatic dissemination via metabolic reprogramming. Twist Bioscience stock is up 5.2% on the day at $96.34. The daily move aligns with the broader bullish chart structure.
Highlights
- Twist Bioscience shares climbed 5.2% after being selected to supply DNA for a prominent chemotherapy research project.
- Analyst sentiment remains strongly positive, though the current $96.34 stock price trades 14% above the median target.
- Technical indicators confirm a sustained bullish trend, with short-term upside likely in the $91.52 to $101.15 range.
The event adds to an already positive backdrop, with 36 of 42 analysts covering Twist Bioscience maintaining a buy rating and none recommending a sell. However, the median price target sits at $82.5, about 14.3% below the current share price. Evercore ISI Group recently updated its stance to in-line with a $102 target, reflecting ongoing scrutiny even as sentiment remains optimistic.
View post on X Loading...
Bullish momentum maintained as price holds above key averages
The daily move aligns with the broader bullish chart structure, reinforcing the positive undertone for Twist Bioscience stock. Price action remains supported by the nearest key level, the Ichimoku Kijun at $94.1, which continues to serve as a technical anchor. Importantly, shares are holding above their MA-20, MA-50, and MA-200, which underpins the ongoing bullish trend on the daily timeframe. No notable resistance levels are identified at this stage, suggesting the path higher is being maintained.
High probability for further gains as trend and range support upside
The stock has registered a sustained move higher with a firm trend, and against that backdrop, the technical signals support a constructive outlook over the next five trading days. There is a very high probability, above 80%, that shares will continue to advance, while the downside probability remains very low at less than 20%. The expected trading range for the coming week is $91.52 to $101.15. On the weekly chart the longer-term picture stays firmly constructive.
Earlier, analysts noted that Twist Bioscience exhibited firm bullish momentum, supported by strong buyer interest but moderated by overbought conditions. The combination of further research partnerships and a continued bullish skew in technical structure suggests that upside participation remains dominant, though traders should monitor for potential reversals if momentum wanes at current elevated levels.
This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Subscribe to TU news
Did you like the article?
Latest Twist Bioscience News
Top News
Top 5 companies for you
United States
-
Afghanistan
-
Albania
-
Algeria
-
Angola
-
Argentina
-
Armenia
-
Australia
-
Austria
-
Azerbaijan
-
Bahamas
-
Bahrain
-
Bangladesh
-
Belarus
-
Belgium
-
Bolivia
-
Botswana
-
Brazil
-
Brunei
-
Bulgaria
-
Cambodia
-
Cameroon
-
Canada
-
Chile
-
China
-
Colombia
-
Congo
-
Costa Rica
-
Cote d'Ivoire
-
Croatia
-
Cuba
-
Cyprus
-
Czechia
-
DR Congo
-
Denmark
-
Dominican Republic
-
Ecuador
-
Egypt
-
El Salvador
-
Estonia
-
Eswatini
-
Ethiopia
-
Finland
-
France
-
Georgia
-
Germany
-
Ghana
-
Greece
-
Haiti
-
Hong Kong
-
Hungary
-
India
-
Indonesia
-
Iran, Islamic republic
-
Iraq
-
Ireland
-
Israel
-
Italy
-
Jamaica
-
Japan
-
Jordan
-
Kazakhstan
-
Kenya
-
Korea
-
Kuwait
-
Kyrgyzstan
-
Laos
-
Latvia
-
Lebanon
-
Lesotho
-
Libya
-
Lithuania
-
Luxembourg
-
Madagascar
-
Malaysia
-
Malta
-
Mauritius
-
Mexico
-
Moldova
-
Mongolia
-
Montenegro
-
Morocco
-
Mozambique
-
Myanmar
-
Namibia
-
Nepal
-
Netherlands
-
New Zealand
-
Nigeria
-
North Macedonia
-
Norway
-
Oman
-
Pakistan
-
Palestine
-
Panama
-
Papua New Guinea
-
Paraguay
-
Peru
-
Philippines
-
Poland
-
Portugal
-
Puerto Rico
-
Qatar
-
Reunion
-
Romania
-
Rwanda
-
Saudi Arabia
-
Serbia
-
Singapore
-
Slovakia
-
Slovenia
-
Somalia
-
South Africa
-
Spain
-
Sri Lanka
-
Sweden
-
Switzerland
-
Syria
-
Taiwan
-
Tajikistan
-
Tanzania
-
Thailand
-
Trinidad and Tobago
-
Tunisia
-
Turkey
-
UAE
-
Uganda
-
Ukraine
-
United Kingdom
-
United States
-
Uruguay
-
Uzbekistan
-
Venezuela
-
Vietnam
-
Yemen
-
Zambia
-
Zimbabwe
- Forex
- Crypto
Live News
